PAULINE PATEL: Open Payments
NPI 1710345939 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,193 in 58 payments from 12 companies in 2025. Trend: 2023 $21 · 2024 $295 · 2025 $1,193
Food & beverage: $1,193
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $464 |
| QOL Medical, LLC | 5 | $161 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $99 |
| GENZYME CORPORATION | 3 | $93 |
| Regeneron Healthcare Solutions, Inc. | 4 | $86 |
| Janssen Biotech, Inc. | 4 | $76 |
| Ardelyx, Inc. | 4 | $66 |
| Daiichi Sankyo Inc. | 2 | $57 |
| Aimmune Therapeutics, Inc. | 2 | $36 |
| Medtronic, Inc. | 1 | $23 |
Products named: RINVOQ, DUPIXENT, Sucraid, XIFAXAN, TREMFYA, CREON, IBSRELA, INJECTAFER.
Industry payments across SC — which companies pay providers there.
